自拟养正桂苓汤联合TP方案对卵巢癌的疗效及T细胞免疫功能的影响
本文选题:卵巢癌 切入点:养正桂苓汤 出处:《黑龙江中医药大学》2017年硕士论文
【摘要】:目的:观察自拟养正桂苓汤联合TP方案对卵巢癌的疗效及T细胞免疫功能的影响。方法:采用完全随机分组法将纳入的60例病例分为治疗组和对照组,其中对照组病例30例,予紫杉醇+顺铂化疗,治疗组病例30例,在西医化疗基础上配合服用自拟养正桂苓汤。化疗采用21天方案,连续观察2个周期,中药口服从化疗第一天开始,日2次各150ml早晚分服,连服6周。观察两组患者的中医证候积分、卡氏评分、肿瘤标志物CA125、T细胞免疫功能及血常规、肝肾功能等安全性指标。结果:1.中医疗效评定:治疗组总有效率为86.67%,对照组总有效率为60.00%,经统计p0.01,差异具有显著统计学意义。2.KPS评分:两组治疗后与治疗前比较,p值均小于0.0 1,差异具有显著统计学意义;且治疗后两组间比较,P=0.0020.01,差异具有显著统计学意义。3.肿瘤标志物CA125:两组治疗后与治疗前比较,p值均小于0.01,差异具有显著统计学意义;且治疗后两组间比较,p=0.0060.01,差异具有显著统计学意义。4.细胞免疫功能:两组治疗后与治疗前比较,p值均小于0.01,差异具有显著统计学意义;且治疗后两组间比较p0.01,差异具有显著统计学意义。5.在不良反应发生率上,两组在白细胞、谷丙转氨酶、谷草转氨酶及肌酐比较上,p均大于0.05,差异无统计学意义。结论:1.自拟养正桂苓汤联合TP方案能够降低卵巢癌患者血清CA125水平。2.自拟养正桂苓汤联合TP方案能够调节T细胞的表达水平,改善卵巢癌患者的免疫状态。3.自拟养正桂苓汤联合TP方案能够改善气虚血瘀型卵巢癌患者的临床症状,提高生活质量。
[Abstract]:Objective: to observe the effect of Yangzhenggui Ling decoction combined with TP regimen on ovarian cancer and T-cell immune function. Methods: 60 cases were randomly divided into treatment group and control group, including 30 cases in control group. Paclitaxel cisplatin chemotherapy was given. 30 cases in the treatment group were treated with self-made Yangzhenggui decoction on the basis of western medicine chemotherapy. The chemotherapy was carried out with a 21-day regimen and two consecutive cycles of observation. The oral administration of traditional Chinese medicine began on the first day of chemotherapy. 150ml was taken twice a day in the morning and evening for 6 weeks. The TCM syndromes score, Karschoff score, tumor marker CA125 T cell immune function and blood routine were observed in the two groups. Results: the total effective rate of the treatment group was 86.67, the total effective rate of the control group was 60.000.The difference was statistically significant (p0.01). 2. KPS score: the two groups were compared with the treatment group before and after treatment. The values were less than 0.01, the difference was statistically significant. The difference between the two groups after treatment was statistically significant (P < 0.01). The tumor marker CA125 was less than 0.01in both groups after treatment and before treatment, and the difference was statistically significant. After treatment, the difference between the two groups was statistically significant. 4. The cellular immune function: after treatment and before treatment, the P value of the two groups was less than 0.01, the difference was statistically significant. After treatment, the difference between the two groups was statistically significant. 5. In the incidence of adverse reactions, the two groups in white blood cells, alanine aminotransferase, Both glutamic oxaloacetic transaminase and creatinine were more than 0.05, the difference was not statistically significant. Conclusion: 1. The combination of Yangzhenggui Ling decoction and TP regimen can reduce the serum CA125 level of ovarian cancer patients .2.The self-made Yangzhenggui Ling decoction combined with TP regimen can adjust the level of serum CA125 in patients with ovarian cancer. The expression level of T cells, Improve the immune state of ovarian cancer patients .3.The combination of Yangzhenggui Ling decoction and TP regimen can improve the clinical symptoms and improve the quality of life of ovarian cancer patients with Qi deficiency and blood stasis type.
【学位授予单位】:黑龙江中医药大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R737.31
【相似文献】
相关期刊论文 前10条
1 周云芳 ,蒋丽蓉 ,王薇 ,肖洁;传染性单核细胞增多症和T细胞免疫[J];临床儿科杂志;2003年08期
2 李敏;;传染性单核细胞增多症患儿的T细胞免疫改变[J];现代预防医学;2007年14期
3 郑翠苹;杨军;徐杰;;中西医结合治疗非何杰金氏淋巴瘤52例临床观察及其对白细胞介素-2、可溶性白细胞介素-2受体、T细胞及红细胞免疫的影响[J];浙江中医杂志;2008年12期
4 张晓红;自身免疫性血小板减少性紫癜的临床转归与T细胞免疫缺陷有关[J];国外医学.输血及血液学分册;1994年03期
5 李卓敏;闫惠平;;原发性胆汁性肝硬化T细胞免疫研究进展[J];北京医学;2013年12期
6 祖庆,王宁玲,瞿志敏,戴海明,徐友和,陶松雪;特发性血小板减少性紫癜患儿T细胞免疫功能的变化[J];安徽医科大学学报;2002年05期
7 黄河;王慧;唐泽丽;杨滨燕;吴长有;;霉酚酸衍生物对小鼠T细胞免疫功能的抑制作用[J];免疫学杂志;2012年09期
8 董毅;吴利先;;T细胞免疫在抗结核杆菌感染中的研究进展[J];现代生物医学进展;2014年18期
9 王宁玲 ,戴海明 ,刘芝璋 ,翟志敏;特发性血小板减少性紫癜患儿T细胞免疫功能研究[J];临床儿科杂志;2003年09期
10 周平,吕枫林,姚咏明,王江,于燕;特发性血小板减少性紫癜患儿T细胞免疫功能的变化[J];中华儿科杂志;1999年01期
相关会议论文 前10条
1 彭军;侯明;;特发性血小板减少性紫癜T细胞免疫失耐受机制[A];第12届全国实验血液学会议论文摘要[C];2009年
2 单保恩;杨兴肖;马鸣;刘丽华;艾军;赵连梅;张小芳;;大鼠骨髓间充质干细胞对T细胞免疫活性的影响[A];2010’全国肿瘤分子标志及应用学术研讨会暨第五届中国中青年肿瘤专家论坛论文汇编[C];2010年
3 单保恩;杨兴肖;马鸣;刘丽华;艾军;赵连梅;张小芳;;大鼠骨髓间充质干细胞对T细胞免疫活性的影响[A];河北省免疫学会第六次免疫学大会资料汇编[C];2010年
4 杨兴肖;单保恩;;大鼠骨髓间充质干细胞对T细胞免疫活性的影响[A];中华医学会第九次全国检验医学学术会议暨中国医院协会临床检验管理专业委员会第六届全国临床检验实验室管理学术会议论文汇编[C];2011年
5 刘敏;王运律;胡琦;孙思明;刘元霞;张晓峰;;补肾颗粒对慢性再生障碍性贫血患者T细胞免疫相关指标影响的临床研究[A];第八届全国中西医结合血液病学术会议论文集[C];2007年
6 潘华新;周联;马方励;;增健与营养适、维康素合用对小鼠T细胞免疫功能的影响[A];第五届全国中医药免疫学术研讨会——暨环境·免疫与肿瘤防治综合交叉会议论文汇编[C];2009年
7 潘];郭晓玲;蔡圣鑫;董作仁;;G-CSF诱导异基因造血干细胞移植供者T细胞免疫耐受机制初探[A];第12届全国实验血液学会议论文摘要[C];2009年
8 姚中强;李茹;栗占国;;Ⅱ型胶原变构肽对胶原性关节炎T细胞免疫的影响[A];全国自身免疫性疾病专题研讨会暨第十一次全国风湿病学学术年会论文汇编[C];2006年
9 向彩春;熊清s,
本文编号:1675155
本文链接:https://www.wllwen.com/yixuelunwen/zlx/1675155.html